window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 26, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Drug Development

  • Drug Development,Global health,Patient Centricity,Research & Development

    Vitamin D shown to reduce liver damage by activating TXNIP gene, study finds

    New study shows how the vitamin D/TXNIP axis modulates ductular [...]

    July 28, 2025
  • Artificial Intelligence,Drug Development,Oncology,Partnerships & Funding,Technology and platforms

    Scientist.com expands AI-powered Tumor Model Finder with XenoSTART cancer models

    Scientist.com has expanded its AI-powered Tumor Model Finder through a [...]

    July 24, 2025
  • Biologics & Biosimilars,Drug Development,European biotech,Partnerships & Funding,Precision medicine,Technology and platforms

    Kling Bio and Sanofi collaborate to accelerate discovery of next-generation antiviral antibodies

    Biotech company Kling Bio has announced a new collaboration with [...]

    July 24, 2025
  • Biologics & Biosimilars,Drug Development,Oncology,Research & Development

    Why immunotherapy sometimes fails: Study reveals unintended effects of antibody design

    A new study from researchers in Japan has uncovered a [...]

    July 24, 2025
  • Drug Development,Research & Development,Technology and platforms

    Sygnature Discovery upgrades high-throughput chemistry platform following £1 million investment

    Sygnature Discovery has completed a major upgrade of its high-throughput [...]

    July 23, 2025
  • Artificial Intelligence,Drug Development,Partnerships & Funding,Research & Development

    AI-powered initiative in Louisiana aims to accelerate ALS drug discovery

    A new AI-led collaboration is being launched to advance drug [...]

    July 23, 2025
  • Biologics & Biosimilars,CDMOs & Manufacturing,Clinical Development,Drug Development,Technology and platforms

    Solvias expands US cGMP testing capabilities with RTP center phase 2 build-out

    Solvias has achieved Current Good Manufacturing Practice (cGMP) readiness at [...]

    July 22, 2025
  • Artificial Intelligence,Clinical Trials,Drug Development,Real world evidence,Research & Development

    QuantHealth clinical trial simulations deliver $31.4m savings and 90% accuracy

    QuantHealth has simulated more than 350 clinical trials using its [...]

    July 23, 2025
  • Biologics & Biosimilars,Drug Development,Market Access & Commercialization,Partnerships & Funding,Technology and platforms

    MSD strengthens commercial capabilities with commitment to Veeva Vault CRM ahead of major launches

    Global pharma leader MSD (Merck outside the US and Canada) [...]

    July 22, 2025
  • Biologics & Biosimilars,Drug Development,Oncology,Research & Development,Technology and platforms

    PhoreMost unveils breakthrough platform to rationalise molecular glue drug discovery

    High-throughput GlueSEEKER platform expands druggable space by identifying novel induced [...]

    July 22, 2025
Previous151617Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • ImmuneOncia Therapeutics and Lonza agree manufacturing partnership for PD-L1 antibody Danburstotug
    Categories: CDMOs & Manufacturing, Cell & Gene Therapy, Immunology, Oncology, Pharmaceuticals and therapeutics, Rare Diseases, Research & Development
  • Vetter recognised as 2026 CDMO Leadership Awards winner in finished dose category
    Categories: CDMOs & Manufacturing, Manufacturing, Market Access & Commercialization, Pharmaceuticals and therapeutics
  • UMass Chan, Caring Cross and Trenchant BioSystems form sickle cell gene therapy manufacturing alliance
    Categories: Cell & Gene Therapy, Hematology, Manufacturing, Partnerships & Funding, Rare Diseases, Research & Development, Technology and platforms
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top